Summary
Experimental evidence suggested that H2-receptor antagonists may inhibit not only hepatic but also adrenal cytochrome P-450 dependent monooxygenases. Therefore, the effects of ranitidine (150 mg b.i.d. over 14 days) on Cortisol metabolism and antipyrine clearance have been investigated in nine healthy volunteers. Urinary excretion of 6β-hydroxycortisol (6β-OHC) and 17-hydroxycorticosteroids (17-OHCS) remained unaffected by ranitidine pretreatment, as did the calculated 6β-OHC/17-OHCS ratio. Only marginal effects were observed on antipyrine kinetics and metabolite formation. We conclude that neither adrenal production of corticosteroids nor their hepatic metabolism is affected by ranitidine administration.
Similar content being viewed by others
References
Smith S.R., Kendall M.J. (1988): Ranitidine versus Cimetidine. A comparison of their potential to cause clinically important drug interactions. Clin. Pharmacokinet., 15, 44–56.
Breen K.J., Bury R., Desmond P.V., et al. (1982): Effect of Cimetidine and ranitidine on hepatic drug metabolism. Clin. Pharmacol. Ther., 31, 297–300.
Friebel P., Walter-Sack I., Ukena D., Czechanowski B., De Vries J., Weber E. (1985): Influence of a single dose of Cimetidine 800 mg and ranitidine 300 mg on oxidative drug transformation (antipyrine clearance). Br. J. Clin. Pharmacol., 20, 546P.
Henry D.A., Macdonald I.A., Kitchingman G., Bell G.D., Langman M.J.S. (1980): Cimetidine and ranitidine: comparison of effects on hepatic drug metabolism. Br. Med. J., 281, 775–777.
Kelly H.W., Powell J.R., Donohue J.F. (1986): Ranitidine at very large doses does not inhibit theophylline elimination. Clin. Pharmacol. Ther., 39, 577–581.
Kirch W., Hoensch H., Janisch H.D. (1984): Interactions and non-interactions with ranitidine. Clin. Pharmacokinet., 9, 493–510.
McCarthy D.M. (1983): Ranitidine or Cimetidine. Ann. Intern. Med., 99, 551–553.
Harris N.L., Brenner D.E., Anthony L.B., Collins J.C., Halter S., Hande K.R. (1988): The influence of ranitidine on the pharmacokinetics and toxicity of doxorubicin in rabbits. Cancer Chemother. Pharmacol., 21, 323–328.
Boidin M.P., Stuumam A., Erdmann W. (1988): Inhibition of steroidogenesis by Cimetidine in man. A double-blind prospective study. Scand. J. Gastroenterol, 23 (Suppl 154), 41–45.
Keynon C.J., Fraser R., Bimie G.G., Connell J.M.C., Lever A.F. (1986): Dose related in vitro effects of ranitidine and Cimetidine on basal and ACTH-stimulated steroidogenesis. Gut, 27, 1143–1146.
Knigge U., Thuesen B., Dejgaard A., Bennett P., Christiansen P.M. (1989): Plasma concentrations of pituitary and peripheral hormones during ranitidine treatment for two years in man with duodenal ulcer. Eur. J. Clin. Pharmacol., 37, 305–307.
Klotz U., Reimann I.W., Ohnhaus E.E. (1983): Effect of ranitidine on the steady state pharmacokinetics of diazepam. Eur. J. Clin. Pharmacol., 24, 357–360.
Eichelbaum M., Spannbrucker N. (1977): Rapid and sensitive method for the determination of antipyrine in biological fluids by high pressure liquid chromatography. J. Chromatogr., 140, 288–292.
Eichelbaum M., Sonntag B., Dengler H.J. (1981): HPLC determination of antipyrine metabolites. Pharmacology, 23, 192–202.
Park B.K. (1978): A direct radioimmunoassay for 6-β-hydroxycortisol in human urine. J. Steroid. Biochem., 9, 963–966.
Sanghvi A., Wight C., Parikh B., Desai H. (1973): Urinary 17-hydroxycorticosteroid determination with p-hydrazino-benzenesulfonic acid-phosphoric acid. Am. J. Clin. Pathol., 60, 684–690.
Schulte H.M., Chrousos G.P., Avgerinos P., et al. (1984): The corticotrophin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency. J. Clin. Endocrinol. Metab., 58, 1054–1062.
Ohnhaus E.E., Park B.K. (1979): Measurement of urinary 6-β-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin. Eur. J. Clin. Pharmacol., 15, 139–145.
Klotz U., Reimann I. (1990): Delayed clearance of diazepam due to Cimetidine. N. Engl. J. Med, 302, 1012–1014.
Roberts R.K., Grice J., Wood L., Petroff V., McGuffie C. (1981): Cimetidine impairs the elimination of theophylline and antipyrine. Gastoenterology, 81, 19–21.
Somogyi A., Muirhead M. (1987): Pharmacokinetic interactions of Cimetidine. Clin. Pharmacokinet., 12, 321–366.
Rendic S., Sunjic V., Toso R., Kajfez F. (1979): Interaction of Cimetidine with liver microsomes. Xenobiotica, 9, 555–564.
Rendic S., Alebic-Kolbah T., Kajfez F., Ruf H.H. (1982): Interaction of ranitidine with liver microsomes. Xenobiotica, 12, 9–17.
Desmond P.V., Mashford M.L., Harraan P.J., Morphea B.J., Breen K.J., Wang Y.M. (1984): Decreased oral warfarin clearance after ranitidine and Cimetidine. Clin. Pharmacol. Ther., 35, 338–341.
Spahn H., Mutschler E., Kirch W., Ohnhaus E.E. (1983): Influence of ranitidine on plasma metoprolol and atenolol concentrations. Br. Med. J., 286, 1546–1547.
Femandes E., Melewicz F.M. (1984): Ranitidine and theophylline (Letter). Ann. Intern. Med, 100, 459.
Gardner M.E., Sikorski G.W. (1985): Ranitidine and theophylline. (Letter). Ann. Intern. Med., 102, 559.
Carlson H.E., Ippoliti A.F. (1977): Cimetidine, an H2-antihistamine, stimulates prolactin secretion in man. J. Clin. Endocrinol. Metab., 45, 367–370.
De Natale G., Vacca M., Preziosi P. (1980): Cimetidine and adrenals. Arzneimittelforsch, 30, 1635–1636.
Delitala G., Devilla L., Pende A., Canessa A. (1982): Effects of the H2-receptor antagonist ranitidine on anterior pituitary hormone secretion in man. Eur. J. Clin. Pharmacol., 22, 207–211.
Edwards C.R.W., Yeo T., Delitala G., Al Dujaili A.S., Boscaro M., Besser G.M. (1981): In vitro studies on the effects of ranitidine on isolated anterior pituitary and adrenal cells. Scand. J. Gastroenterol, 16 (Suppl 69), 75–77.
Sancho J.M., Garcia Robles R., Mancheno E., Paya C., Rodicio J.L. Ruilope L. (1984): Interference by ranitidine with aldosterone secretion in vivo. Eur. J. Clin. Pharmacol., 27, 495–497.
Author information
Authors and Affiliations
Additional information
[§ Deceased]
Rights and permissions
About this article
Cite this article
Mönig, H., Hoffmann, K., Ohnhaus, E.E. et al. Ranitidine treatment and cortisol metabolism in man. European Journal of Drug Metabolism and Pharmacokinetics 17, 9–12 (1992). https://doi.org/10.1007/BF03189981
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189981